We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$21.6M
2
TCOM icon
Trip.com Group
TCOM
+$20.5M
3
AOD
abrdn Total Dynamic Dividend Fund
AOD
+$12.1M
4
GDV icon
Gabelli Dividend & Income Trust
GDV
+$12M
5
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
+$11.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTTB icon
1051
Q32 Bio
QTTB
$464M
$9K ﹤0.01%
57
-1
-2% -$211
ATNX
1052
DELISTED
Athenex, Inc. Common Stock
ATNX
$9K ﹤0.01%
106
-1
-0.9% -$192
FLXN
1053
DELISTED
Flexion Therapeutics, Inc.
FLXN
$9K ﹤0.01%
1,115
-40
-3% -$458
BDSI
1054
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$9K ﹤0.01%
2,310
-10
-0.4% -$41
ACET icon
1055
Adicet Bio
ACET
$74.7M
$8K ﹤0.01%
43
+15
+54% +$3.44K
CLLS
1056
Cellectis
CLLS
$285M
$8K ﹤0.01%
435
+25
+6% +$618
FULC icon
1057
Fulcrum Therapeutics
FULC
$297M
$8K ﹤0.01%
725
+95
+15% +$1.18K
PBYI icon
1058
Puma Biotechnology
PBYI
$454M
$8K ﹤0.01%
905
-10
-1% -$112
SYRE icon
1059
Spyre Therapeutics
SYRE
$9.25B
$8K ﹤0.01%
44
– –
ENR icon
1060
Energizer
ENR
$1.55B
$7K ﹤0.01%
165
+24
+17% +$1.1K
FINV
1061
FinVolution Group
FINV
$1.15B
$7K ﹤0.01%
1,110
+740
+200% +$3.94K
IMUX icon
1062
Immunic
IMUX
$195M
$7K ﹤0.01%
49
+1
+2% +$170
KRRO icon
1063
Korro Bio
KRRO
$195M
$7K ﹤0.01%
15
-1
-6% -$1.94K
UBX
1064
DELISTED
Unity Biotechnology
UBX
$7K ﹤0.01%
121
-1
-0.8% -$68
YARW
1065
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$7K ﹤0.01%
1
– –
CBAY
1066
DELISTED
Cymabay Therapeutics
CBAY
$7K ﹤0.01%
1,595
+15
+0.9% +$81
PRTK
1067
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$7K ﹤0.01%
1,050
– –
SURF
1068
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$7K ﹤0.01%
930
-35
-4% -$350
ELVT
1069
DELISTED
Elevate Credit, Inc.
ELVT
$7K ﹤0.01%
2,490
+1,660
+200% +$6.92K
KLDO
1070
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$7K ﹤0.01%
940
+90
+11% +$980
ABUS icon
1071
Arbutus Biopharma
ABUS
$915M
$6K ﹤0.01%
1,940
-10
-0.5% -$39
AWR icon
1072
American States Water
AWR
$3.46B
$6K ﹤0.01%
85
+10
+13% +$770
CABA icon
1073
Cabaletta Bio
CABA
$455M
$6K ﹤0.01%
545
-5
-0.9% -$61
FCFS icon
1074
FirstCash
FCFS
$8.78B
$6K ﹤0.01%
103
+16
+18% +$1.01K
KMDA icon
1075
Kamada
KMDA
$419M
$6K ﹤0.01%
1,025
-45
-4% -$298
41 42
43
44 45

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.